Applied UV (AUVI) Appoints Jos Luhukay to its Board

Applied UV, Inc. (NasdaqCM: AUVI) (“Applied UV” or the “Company”), a pathogen elimination technology company that applies the power of narrow-range ultraviolet light (“UVC”) for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, announced that Joseph (Jos) Luhukay has joined the Board of Directors. Jos Luhukay joins Applied UV’s extensive Executive leadership team and Board as the Company continues the global market expansion of its patented, disruptive, and highly effective suite of fixed and mobile air purification solutions (Airocide and Scientific Air).

Jos Luhukay is a seasoned international banking Executive with over 40 years of experience leading many of Indonesia’s leading financial institutions and a former Ernst and Young Partner who led the business advisory and risk consulting practice which provided services in corporate governance, risk management, information systems audit and advisory, internal audit and policy and operational process development. Jos Luhukay’s distinguished career brings Applied UV a strong track record in delivering profitable growth for internationally recognized bank and investment banking companies including: Chief Operating Officer of Bank Niaga, Bahana Pembinaan Usaha Indonesia, a main Indonesian Government-owned investment Bank, Chief Operating Officer & Executive Director of the Jakarta Initiative Task Force (set up by the Ministry of Finance) where he managed a $65B portfolio and restructured over 20% of it in less than 2 years, President Director of Bank Lippo, where he was awarded “CEO of the Year” in 2006 by SWA Magazine (the largest business magazine in Indonesia), Deputy President of Temasek-owned Bank Danamon and his most recent role as President Director of Rabobank International Indonesia, a 30 year old Dutch owned Commercial Bank in Indonesia. Jos Luhukay holds an engineering degree in electrical engineering from the University of Indonesia, a Master’s and PhD in Computer Science from the University of Illinois at Urbana-Champaign.

John Andrews, Applied UV’s Chief Executive Officer, and Director stated, “We welcome Jos to our Board of Directors. During his distinguished career Jos has demonstrated a track record of providing corporate governance, completing complex financial execution and international regulatory compliance with financial institutions that will complement and broaden our existing Board of Directors. Jos’s international business connections throughout Southeast Asia and Europe will prove valuable as we continue our international expansion. Jos’s leadership and business acumen will provide additional stewardship as we grow our globally recognized suite of both fixed and mobile air purification solutions and is another confident step we are undertaking, as we execute on our global strategy.”

Jos Luhukay stated, “I am truly looking forward to working with the leadership team in bringing forth our advanced air purification technologies throughout the world. Both the health & medical and waste-reduction in food production, transportation and storage sectors will benefit highly from these technologies. Given the global conditions we are in, Applied UV offers timely and highly required solutions internationally.”

Both Monica Woo and Jos Luhukay were nominated by majority shareholder and approved at Applied UV’s Annual Shareholder Meeting held on May 17th, 2022, replacing Gene Bauer and Joel Kanter. On May 17th, 2022, Alastair Clemow resigned from our Board.

Max Munn, Applied UV President and Director stated, “On behalf of the entire Company, I’d like to thank Gene Bauer, Joel Kanter and Alastair Clemow for their tireless efforts the past two years. The stewardship and leadership they provided to our Board was invaluable and has been instrumental in guiding the Company since our IPO.”

You May Also Be Interested In

• Diginex reports 77% revenue rise but $31M net loss in FY2026
• Applied Aerospace & Defense (AADX) PT Lowered to $23 at BofA Securities
• Evogene chairman to address dissident shareholders on results call